跳至主要内容
临床试验/ISRCTN22637771
ISRCTN22637771已完成不适用

Interventional therapy of bifurcation lesions: A flow-guided concept to treat side branches in bifurcation lesions - a prospective randomized clinical study (THUEringer BIfurcation Study, THUEBIS-Study)

Berka Clinic, Department of Cardiology (Zentralklinik Bad Berka, Klinik für Kardiologie) (Germany)0 个研究点目标入组 110 人开始时间: 2008年2月14日最近更新:

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
110

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

性别
All

入选标准

  • 1. Male or female patients older than 18 years of age
  • 2. Diagnosis of stable angina or silent ischemia
  • 3. Presence of a de novo, true coronary bifurcation lesion, defined as stenosis >50% in both the Main Branch (MB) and the ostium of the Side Branch (SB). Both branches were required to have a Thrombolysis In Myocardial Infarction (TIMI) flow of at least 2 or 3 as well as a reference vessel size >2.25 mm by visual estimation or a relevant SB which the operator would not have wanted to loosen during the procedure. If two commensurate vessels were present, the main branch was defined as the largest of the two vessels involved.

排除标准

  • 1. A myocardial infarction in the 24 hours preceding treatment (STEMI and NSTEMI)
  • 2. Stenosis of the left main coronary artery unprotected by a graft
  • 3. Cardiogenic shock
  • 4. Angiographically visible thrombus within the target lesion, restenosis or total occlusion of the target lesion
  • 5. Life expectancy <1 year
  • 6. Suspected intolerance to paclitaxel, aspirin or clopidogrel

研究者

发起方
Berka Clinic, Department of Cardiology (Zentralklinik Bad Berka, Klinik für Kardiologie) (Germany)

相似试验